Neutrophils to lymphocytes ratio between benign and malignant thyroid nodule

Nazia Haider1, Zahid Mahmood2, Fizzah Khalid3

  • 1Dr. Nazia Haider (MBBS, FCPS General Surgery Resident), Jinnah Postgraduate Medical Centre, Karachi, Pakistan.

Insights

The Neutrophils to Lymphocytes Ratio (NLR) does not effectively differentiate between benign and malignant thyroid nodules. Preoperative NLR values showed no significant difference in this study.

Area of Science:

  • Endocrinology and Oncology
  • Hematology
  • Surgical Pathology

Background:

  • Thyroid nodules are common, with a subset being malignant.
  • Distinguishing benign from malignant nodules preoperatively is crucial for patient management.
  • The Neutrophils to Lymphocytes Ratio (NLR) is an inflammatory marker that has been investigated for various conditions.

Purpose of the Study:

  • To investigate the association between preoperative Neutrophils to Lymphocytes Ratio (NLR) values and the distinction between benign and malignant thyroid nodules.
  • To assess the diagnostic utility of NLR in differentiating thyroid nodule types.

Main Methods:

  • A cross-sectional clinical study involving 216 patients who underwent thyroidectomy.
  • Patients were categorized into benign thyroid nodule (BTN) and malignant thyroid nodule (MTN) groups based on histopathology.
  • Preoperative complete blood count data was analyzed to calculate NLR.

Main Results:

  • No statistically significant difference was observed in mean neutrophil counts between the BTN (4.26 ± 2.8) and MTN (4.41 ± 2.2) groups (p=0.71).
  • Mean lymphocyte counts were also similar between groups: BTN (3.81 ± 0.9) and MTN (3.61 ± 1.2) (p=0.18).
  • The mean NLR values were comparable: 1.19 ± 2.2 for BTN and 1.22 ± 1.8 for MTN (p=0.92).

Conclusions:

  • Preoperative NLR values do not provide sufficient evidence to differentiate between benign and malignant thyroid nodules.
  • Neutrophil count, lymphocyte count, and NLR are not reliable preoperative biomarkers for distinguishing thyroid nodule malignancy.
Abstract

Related Concept Videos

The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...